Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Cocrystal structure of meningococcal factor H binding protein variant 3 reveals a new crossprotective epitope recognized by human mAb 1E6.

Bianchi F, Veggi D, Santini L, Buricchi F, Bartolini E, Lo Surdo P, Martinelli M, Finco O, Masignani V, Bottomley MJ, Maione D, Cozzi R.

FASEB J. 2019 Nov;33(11):12099-12111. doi: 10.1096/fj.201900374R. Epub 2019 Oct 5.

2.

Human protective response induced by meningococcus B vaccine is mediated by the synergy of multiple bactericidal epitopes.

Giuliani M, Bartolini E, Galli B, Santini L, Lo Surdo P, Buricchi F, Bruttini M, Benucci B, Pacchiani N, Alleri L, Donnarumma D, Pansegrau W, Peschiera I, Ferlenghi I, Cozzi R, Norais N, Giuliani MM, Maione D, Pizza M, Rappuoli R, Finco O, Masignani V.

Sci Rep. 2018 Feb 27;8(1):3700. doi: 10.1038/s41598-018-22057-7.

3.

A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster vaccines in adults.

Leroux-Roels G, Lattanzi M, Solis CD, Contorni M, Costantini M, Moraschini L, Bardelli M, Bertholet S, Borgogni E, Buricchi F, Cantisani R, Faenzi E, Finco O, Leuzzi R, Pizza M, Rosa D, Schiavetti F, Seubert A, Spensieri F, Volpini G, Zedda L, Giudice GD, Galgani I.

Hum Vaccin Immunother. 2018 Jan 2;14(1):45-58. doi: 10.1080/21645515.2017.1385686. Epub 2017 Nov 27.

4.

Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined.

Biagini M, Spinsanti M, De Angelis G, Tomei S, Ferlenghi I, Scarselli M, Rigat F, Messuti N, Biolchi A, Muzzi A, Anderloni G, Brunelli B, Cartocci E, Buricchi F, Tani C, Stella M, Moschioni M, Del Tordello E, Colaprico A, Savino S, Giuliani MM, Delany I, Pizza M, Costantino P, Norais N, Rappuoli R, Masignani V.

Proc Natl Acad Sci U S A. 2016 Mar 8;113(10):2714-9. doi: 10.1073/pnas.1521142113. Epub 2016 Feb 17.

5.

Optimized fluorescent labeling to identify memory B cells specific for Neisseria meningitidis serogroup B vaccine antigens ex vivo.

Nair N, Buti L, Faenzi E, Buricchi F, Nuti S, Sammicheli C, Tavarini S, Popp MW, Ploegh H, Berti F, Pizza M, Castellino F, Finco O, Rappuoli R, Del Giudice G, Galli G, Bardelli M.

Immun Inflamm Dis. 2013 Oct;1(1):3-13. doi: 10.1002/iid3.3. Epub 2013 Oct 30.

6.

Two cross-reactive monoclonal antibodies recognize overlapping epitopes on Neisseria meningitidis factor H binding protein but have different functional properties.

Faleri A, Santini L, Brier S, Pansegrau W, Lo Surdo P, Scarselli M, Buricchi F, Volpini G, Genovese A, van der Veen S, Lea S, Tang CM, Savino S, Pizza M, Finco O, Norais N, Masignani V.

FASEB J. 2014 Apr;28(4):1644-53. doi: 10.1096/fj.13-239012. Epub 2013 Dec 26.

PMID:
24371123
7.

Ex vivo analysis of human memory B lymphocytes specific for A and B influenza hemagglutinin by polychromatic flow-cytometry.

Bardelli M, Alleri L, Angiolini F, Buricchi F, Tavarini S, Sammicheli C, Nuti S, Degl'Innocenti E, Isnardi I, Fragapane E, Del Giudice G, Castellino F, Galli G.

PLoS One. 2013 Aug 15;8(8):e70620. doi: 10.1371/journal.pone.0070620. eCollection 2013.

8.

Human circulating influenza-CD4+ ICOS1+IL-21+ T cells expand after vaccination, exert helper function, and predict antibody responses.

Spensieri F, Borgogni E, Zedda L, Bardelli M, Buricchi F, Volpini G, Fragapane E, Tavarini S, Finco O, Rappuoli R, Del Giudice G, Galli G, Castellino F.

Proc Natl Acad Sci U S A. 2013 Aug 27;110(35):14330-5. doi: 10.1073/pnas.1311998110. Epub 2013 Aug 12.

9.

Impact of preexisting memory to seasonal A/H1N1 influenza virus on the immune response following vaccination against avian A/H5N1 virus.

Buricchi F, Bardelli M, Malzone C, Capecchi B, Nicolay U, Fragapane E, Castellino F, Del Giudice G, Galli G, Finco O.

Eur J Immunol. 2013 Mar;43(3):641-8. doi: 10.1002/eji.201242563. Epub 2013 Jan 24.

10.

One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies.

Faenzi E, Zedda L, Bardelli M, Spensieri F, Borgogni E, Volpini G, Buricchi F, Pasini FL, Capecchi PL, Montanaro F, Belli R, Lattanzi M, Piccirella S, Montomoli E, Ahmed SS, Rappuoli R, Del Giudice G, Finco O, Castellino F, Galli G.

Vaccine. 2012 Jun 8;30(27):4086-94. doi: 10.1016/j.vaccine.2012.04.020. Epub 2012 Apr 19.

PMID:
22521851
11.

Approach to discover T- and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines.

Finco O, Frigimelica E, Buricchi F, Petracca R, Galli G, Faenzi E, Meoni E, Bonci A, Agnusdei M, Nardelli F, Bartolini E, Scarselli M, Caproni E, Laera D, Zedda L, Skibinski D, Giovinazzi S, Bastone R, Ianni E, Cevenini R, Grandi G, Grifantini R.

Proc Natl Acad Sci U S A. 2011 Jun 14;108(24):9969-74. doi: 10.1073/pnas.1101756108. Epub 2011 May 31.

12.

CT043, a protective antigen that induces a CD4+ Th1 response during Chlamydia trachomatis infection in mice and humans.

Meoni E, Faenzi E, Frigimelica E, Zedda L, Skibinski D, Giovinazzi S, Bonci A, Petracca R, Bartolini E, Galli G, Agnusdei M, Nardelli F, Buricchi F, Norais N, Ferlenghi I, Donati M, Cevenini R, Finco O, Grandi G, Grifantini R.

Infect Immun. 2009 Sep;77(9):4168-76. doi: 10.1128/IAI.00344-09. Epub 2009 Jul 13.

13.

Proliferation versus migration in platelet-derived growth factor signaling: the key role of endocytosis.

De Donatis A, Comito G, Buricchi F, Vinci MC, Parenti A, Caselli A, Camici G, Manao G, Ramponi G, Cirri P.

J Biol Chem. 2008 Jul 18;283(29):19948-56. doi: 10.1074/jbc.M709428200. Epub 2008 May 21.

14.

Redox regulation of anoikis: reactive oxygen species as essential mediators of cell survival.

Giannoni E, Buricchi F, Grimaldi G, Parri M, Cialdai F, Taddei ML, Raugei G, Ramponi G, Chiarugi P.

Cell Death Differ. 2008 May;15(5):867-78. doi: 10.1038/cdd.2008.3. Epub 2008 Feb 8.

15.
16.

Redox-dependent and ligand-independent trans-activation of insulin receptor by globular adiponectin.

Fiaschi T, Buricchi F, Cozzi G, Matthias S, Parri M, Raugei G, Ramponi G, Chiarugi P.

Hepatology. 2007 Jul;46(1):130-9.

PMID:
17526025
17.

EphrinA1 activates a Src/focal adhesion kinase-mediated motility response leading to rho-dependent actino/myosin contractility.

Parri M, Buricchi F, Giannoni E, Grimaldi G, Mello T, Raugei G, Ramponi G, Chiarugi P.

J Biol Chem. 2007 Jul 6;282(27):19619-28. Epub 2007 Apr 22.

18.

Redox regulation of ephrin/integrin cross-talk.

Buricchi F, Giannoni E, Grimaldi G, Parri M, Raugei G, Ramponi G, Chiarugi P.

Cell Adh Migr. 2007 Jan-Mar;1(1):33-42. Epub 2007 Jan 29.

19.

Protein tyrosine phosphorylation and reversible oxidation: two cross-talking posttranslation modifications.

Chiarugi P, Buricchi F.

Antioxid Redox Signal. 2007 Jan;9(1):1-24. Review.

PMID:
17115885
20.

During muscle ageing the activation of the mitogenic signalling is not sufficient to guarantee cellular duplication.

Buricchi F, Chiarugi P, Fiaschi T, Giannoni E, Magnelli L, Fanti E, Raugei G, Ramponi G.

Ital J Biochem. 2005 Sep-Dec;54(3-4):258-67.

PMID:
16688935
21.

EphrinA1 repulsive response is regulated by an EphA2 tyrosine phosphatase.

Parri M, Buricchi F, Taddei ML, Giannoni E, Raugei G, Ramponi G, Chiarugi P.

J Biol Chem. 2005 Oct 7;280(40):34008-18. Epub 2005 Jul 28.

22.

Intracellular reactive oxygen species activate Src tyrosine kinase during cell adhesion and anchorage-dependent cell growth.

Giannoni E, Buricchi F, Raugei G, Ramponi G, Chiarugi P.

Mol Cell Biol. 2005 Aug;25(15):6391-403.

23.

Insulin inhibits platelet-derived growth factor-induced cell proliferation.

Cirri P, Taddei ML, Chiarugi P, Buricchi F, Caselli A, Paoli P, Giannoni E, Camici G, Manao G, Raugei G, Ramponi G.

Mol Biol Cell. 2005 Jan;16(1):73-83. Epub 2004 Nov 3.

24.

Down-regulation of platelet-derived growth factor receptor signaling during myogenesis.

Fiaschi T, Chiarugi P, Buricchi F, Giannoni E, Taddei ML, Magnelli L, Cozzi G, Raugei G, Ramponi G.

Cell Mol Life Sci. 2003 Dec;60(12):2721-35.

PMID:
14685695
25.

Lymphocyte function-associated antigen-1-mediated T cell adhesion is impaired by low molecular weight phosphotyrosine phosphatase-dependent inhibition of FAK activity.

Giannoni E, Chiarugi P, Cozzi G, Magnelli L, Taddei ML, Fiaschi T, Buricchi F, Raugei G, Ramponi G.

J Biol Chem. 2003 Sep 19;278(38):36763-76. Epub 2003 Jun 18.

26.

Beta-catenin interacts with low-molecular-weight protein tyrosine phosphatase leading to cadherin-mediated cell-cell adhesion increase.

Taddei ML, Chiarugi P, Cirri P, Buricchi F, Fiaschi T, Giannoni E, Talini D, Cozzi G, Formigli L, Raugei G, Ramponi G.

Cancer Res. 2002 Nov 15;62(22):6489-99.

27.

Insight into the role of low molecular weight phosphotyrosine phosphatase (LMW-PTP) on platelet-derived growth factor receptor (PDGF-r) signaling. LMW-PTP controls PDGF-r kinase activity through TYR-857 dephosphorylation.

Chiarugi P, Cirri P, Taddei ML, Giannoni E, Fiaschi T, Buricchi F, Camici G, Raugei G, Ramponi G.

J Biol Chem. 2002 Oct 4;277(40):37331-8. Epub 2002 Jul 30.

28.

New perspectives in PDGF receptor downregulation: the main role of phosphotyrosine phosphatases.

Chiarugi P, Cirri P, Taddei ML, Talini D, Doria L, Fiaschi T, Buricchi F, Giannoni E, Camici G, Raugei G, Ramponi G.

J Cell Sci. 2002 May 15;115(Pt 10):2219-32.

29.

Low molecular weight protein-tyrosine phosphatase is involved in growth inhibition during cell differentiation.

Fiaschi T, Chiarugi P, Buricchi F, Giannoni E, Taddei ML, Talini D, Cozzi G, Zecchi-Orlandini S, Raugei G, Ramponi G.

J Biol Chem. 2001 Dec 28;276(52):49156-63. Epub 2001 Oct 10.

30.

Low molecular weight protein-tyrosine phosphatase controls the rate and the strength of NIH-3T3 cells adhesion through its phosphorylation on tyrosine 131 or 132.

Chiarugi P, Taddei ML, Cirri P, Talini D, Buricchi F, Camici G, Manao G, Raugei G, Ramponi G.

J Biol Chem. 2000 Dec 1;275(48):37619-27.

Supplemental Content

Loading ...
Support Center